BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Song X, Fan J, Liu L, Liu X, Gao F. Coumarin derivatives with anticancer activities: An update. Arch Pharm 2020;353:2000025. [DOI: 10.1002/ardp.202000025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Wu Y, Chen J, Liao H, Shu X, Duan L, Yang X, He W. Electrochemical transient iodination and coupling for selenylated 4-anilinocoumarin synthesis. Green Synthesis and Catalysis 2021;2:233-6. [DOI: 10.1016/j.gresc.2021.03.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 10.0] [Reference Citation Analysis]
2 Charris KE, Rodrigues JR, Ramírez H, Fernandez-Moreira E, Ángel JE, Charris JE. Synthesis of 5H-indeno[1,2-b]pyridine derivatives: Antiproliferative and antimetastatic activities against two human prostate cancer cell lines. Arch Pharm (Weinheim) 2021;354:e2100092. [PMID: 33928662 DOI: 10.1002/ardp.202100092] [Reference Citation Analysis]
3 Liu X, Dong Y, Alizade V, Khutsishvili M, Atha D, Borris RP, Clark BR. Molecular networking-driven isolation of 8'-Glycosylated biscoumarins from Cruciata articulata. Phytochemistry 2021;190:112856. [PMID: 34233243 DOI: 10.1016/j.phytochem.2021.112856] [Reference Citation Analysis]
4 Carneiro A, Matos MJ, Uriarte E, Santana L. Trending Topics on Coumarin and Its Derivatives in 2020. Molecules 2021;26:501. [PMID: 33477785 DOI: 10.3390/molecules26020501] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Balewski Ł, Szulta S, Jalińska A, Kornicka A. A Mini-Review: Recent Advances in Coumarin-Metal Complexes With Biological Properties. Front Chem 2021;9:781779. [PMID: 34926402 DOI: 10.3389/fchem.2021.781779] [Reference Citation Analysis]
6 Phutdhawong W, Chuenchid A, Taechowisan T, Sirirak J, Phutdhawong WS. Synthesis and Biological Activity Evaluation of Coumarin-3-Carboxamide Derivatives. Molecules 2021;26:1653. [PMID: 33809679 DOI: 10.3390/molecules26061653] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Adimule VM, Nandi SS, Kerur SS, Khadapure SA, Chinnam S. Recent Advances in the One-Pot Synthesis of Coumarin Derivatives from Different Starting Materials Using Nanoparticles: A Review. Top Catal. [DOI: 10.1007/s11244-022-01571-z] [Reference Citation Analysis]
8 Stepanenko I, Babak MV, Spengler G, Hammerstad M, Popovic-Bijelic A, Shova S, Büchel GE, Darvasiova D, Rapta P, Arion VB. Coumarin-Based Triapine Derivatives and Their Copper(II) Complexes: Synthesis, Cytotoxicity and mR2 RNR Inhibition Activity. Biomolecules 2021;11:862. [PMID: 34207929 DOI: 10.3390/biom11060862] [Reference Citation Analysis]
9 Keri RS, Budagumpi S, Balappa Somappa S. Synthetic and natural coumarins as potent anticonvulsant agents: A review with structure-activity relationship. J Clin Pharm Ther 2022. [PMID: 35288962 DOI: 10.1111/jcpt.13644] [Reference Citation Analysis]
10 Xu Z, Chen Q, Zhang Y, Liang C. Coumarin-based derivatives with potential anti-HIV activity. Fitoterapia 2021;150:104863. [PMID: 33582266 DOI: 10.1016/j.fitote.2021.104863] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
11 Feng LS, Su WQ, Cheng JB, Xiao T, Li HZ, Chen DA, Zhang ZL. Benzimidazole hybrids as anticancer drugs: An updated review on anticancer properties, structure-activity relationship, and mechanisms of action (2019-2021). Arch Pharm (Weinheim) 2022;:e2200051. [PMID: 35385159 DOI: 10.1002/ardp.202200051] [Reference Citation Analysis]
12 Bakare SB. Synthesis and anticancer evaluation of some coumarin and azacoumarin derivatives. Polish Journal of Chemical Technology 2021;23:27-34. [DOI: 10.2478/pjct-2021-0013] [Reference Citation Analysis]
13 Simic M, Petkovic M, Jovanovic P, Jovanovic M, Tasic G, Besu I, Zizak Z, Aleksic I, Nikodinovic-Runic J, Savic V. Fragment-type 4-azolylcoumarin derivatives with anticancer properties. Arch Pharm (Weinheim) 2021;:e2100238. [PMID: 34374111 DOI: 10.1002/ardp.202100238] [Reference Citation Analysis]
14 G AC, Gondru R, Li Y, Banothu J. Coumarin-benzimidazole hybrids: A review of developments in medicinal chemistry. Eur J Med Chem 2022;227:113921. [PMID: 34715585 DOI: 10.1016/j.ejmech.2021.113921] [Reference Citation Analysis]
15 Wang R. Current perspectives on naturally occurring saponins as anticancer agents. Arch Pharm (Weinheim) 2022;:e2100469. [PMID: 35119132 DOI: 10.1002/ardp.202100469] [Reference Citation Analysis]
16 de Almeida PSVB, de Arruda HJ, Sousa GLS, Ribeiro FV, de Azevedo-França JA, Ferreira LA, Guedes GP, Silva H, Kummerle AE, Neves AP. Cytotoxicity evaluation and DNA interaction of RuII-bipy complexes containing coumarin-based ligands. Dalton Trans 2021;50:14908-19. [PMID: 34609400 DOI: 10.1039/d1dt01567b] [Reference Citation Analysis]
17 Yang W, Xuan B, Li X, Si H, Chen A. Therapeutic potential of 1,2,3-triazole hybrids for leukemia treatment. Arch Pharm (Weinheim) 2022;:e2200106. [PMID: 35532286 DOI: 10.1002/ardp.202200106] [Reference Citation Analysis]
18 Harismah K, Da’i M, Azimzadeh-sadeghi S, Poursafa P, Mirzaei M, Salarrezaei E. Interactions of coumarin derivatives with monoamine oxidase biomarkers: In silico approach. MGC 2021. [DOI: 10.3233/mgc-210162] [Reference Citation Analysis]